<DOC>
	<DOCNO>NCT03012971</DOCNO>
	<brief_summary>A majority elderly patient undergo surgery malignant tumor . For patient , postoperative tumor recurrence metastasis main factor worsen long-term outcome . The investigator hypothesize dexmedetomidine supplement analgesia elderly patient cancer surgery may help maintain immune function improve long-term outcome , possibly relieve stress inflammatory response , improve analgesic efficacy sleep quality , reduce delirium incidence .</brief_summary>
	<brief_title>Dexmedetomidine Supplemented Analgesia 3-Year Survival After Cancer Surgery</brief_title>
	<detailed_description>A majority elderly patient undergo surgery malignant tumor . For patient , postoperative tumor recurrence metastasis main factor worsen quality life shorten duration survival . Perioperative immune function key element influence postoperative tumor recurrence metastasis ; subject impact many factor . Studies show elevated cortisol level inflammation provoke surgical stress result suppression immune function , whereas dexmedetomidine alleviates elevate cortisol level inhibit excessive inflammation ; high-dose opioids inhibit immune function increase invasiveness tumor cell , whereas dexmedetomidine reduces consumption opioids perioperative period ; postoperative sleep disturbance also impair immune function , whereas dexmedetomidine improve sleep quality patient surgery ; occurrence postoperative delirium associate increased mortality , whereas dexmedetomidine reduces delirium incidence . The investigator hypothesize dexmedetomidine supplement analgesia elderly patient cancer surgery may improve long-term outcome , possibly relieve stress inflammatory response , improve analgesic efficacy sleep quality , reduce delirium incidence .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Age &gt; = 65 year , &lt; 90 year ; Scheduled undergo cancer surgery general anesthesia expect duration surgery &gt; =2 hour ; The diagnosis primary malignancy , without preoperative radio chemotherapy ; Patientcontrolled intravenous analgesia plan postoperative analgesia . Refuse participate ; Preoperative history schizophrenia , epilepsy , parkinsonism myasthenia gravis ; Inability communicate preoperative period coma , profound dementia language barrier ; Presence preoperative sleep apnea ( diagnosed sleep apnea , STOPBang score &gt; = 3 ) ; Brain trauma neurosurgery ; Preoperative leave ventricular ejection fraction &lt; 30 % , sick sinus syndrome , severe sinus bradycardia ( &lt; 50 beat per minute ) , seconddegree atrioventricular block without pacemaker ; Severe hepatic dysfunction ( ChildPugh class C ) ; Severe renal dysfunction ( requirement renal replacement therapy surgery ) ; ASA classification &gt; = IV unlikely survive 24 hour surgery .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Elderly</keyword>
	<keyword>Surgery</keyword>
	<keyword>Analgesia</keyword>
	<keyword>Dexmedetomidine</keyword>
	<keyword>Long-term outcome</keyword>
</DOC>